Combogesic®

Dual action pain relief. For use only after trying paracetamol or ibuprofen first.

Combogesic

Combogesic® is a unique, patented combination of paracetamol 500mg and ibuprofen 150mg, that combines the power of these two ingredients to provide superior pain relief than paracetamol or ibuprofen alone, and reduce fever and inflammation.

Active ingredients

Paracetamol 500mg and ibuprofen 150mg.
Also contains Lactose monohydrate.

Dosage

Take 1–2 tablets with a large glass of water.
Repeat the dose every 6 hours, as required, up to a maximum of 6 tablets in 24 hours.
COMBOGESIC® should not be taken for longer than three days, unless advised otherwise by a doctor. COMBOGESIC® should not be combined with any other medicines containing paracetamol or ibuprofen.

Warnings

This preparation is for the relief of minor and temporary ailments and should be used strictly as directed. Do not give to children under 18 years of age. Adults: Keep to the recommended dose. This medicine is for short-term use and is not recommended for use beyond 3 days. Excessive use can be harmful and increase the risk of heart attack, stroke or liver damage.

Do Not Use If:
If you are pregnant or trying to become pregnant.
If you have impaired kidney function.
If you have heart failure.
If you are allergic to paracetamol, ibuprofen, aspirin or other anti-inflammatory medicines.
If you get an allergic reaction, stop taking and see your doctor immediately. Also contains lactose.
If you get an allergic reaction, stop taking and see your doctor immediately.

Unless a doctor has told you to, do not take Combogesic®:
If you have asthma.
If you are aged 65 years or over.
With other products containing paracetamol, ibuprofen, aspirin or other anti-inflammatory medicines or with medicines you are taking regularly.

If an overdose is taken or suspected, ring the National Poisons Information Service (NPIS). In England, Scotland and Wales contact NHS 111/NHS 24 by dialling 111. In Northern Ireland contact your local GP. In Republic of Ireland call 01 809 2166. Or go to hospital straight away even if you feel well because of the risk of delayed, serious liver damage.

Available pack sizes

16s

Dose form

Tablet

May 1, 2024

AFT Licenses Maxigesic® IV in Brazil

We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…

Read More

April 24, 2024

AFT, Massey Ventures, Gilles McIndoe to develop scar treatment

AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….

Read More

March 5, 2024

AFT makes further progress in international markets

AFT Pharmaceuticals provides an update on recent progress it has made in international markets….

Read More
Where can I find out more about your product range?
You can find further information about our products on the Product page.
I am interested in partnering with you as a licensee/licensor, how do I get in touch?
Please use the enquiry form on the Contact Us page and someone will be in touch.
How can I work at AFT?
If we have any current vacancies, you can find them on the Careers page.
Where can I report adverse drug reactions?
Please get in touch with us at infouk@aftpharm.com or go to our Contact Us page.
Can I buy products directly off your website?
Explore our online shops to purchase products directly from New Zealand or Australia, or visit our individual brand websites to find global stockists for in-store and online purchases.
How do I invest in AFT?
Head to our Investors website to find out more about how you can invest with AFT Pharmaceuticals.